Apollo Hospitals reported a robust Q1 FY2027 with consolidated revenue up 21% to ₹7,043 crore and profit after tax surging 34% to ₹581 crore. The company also plans to add over 5,800 beds in five years.
Apollo Hospitals Reports Strong Q1 FY2027 Performance
Consolidated Revenue: ₹7,043 Crore
Consolidated PAT: ₹581 Crore
Reader Takeaway: Strong revenue growth and capacity expansion plans support future outlook, but legal proceedings pose a watch point.
What just happened
Apollo Hospitals Enterprise Ltd has announced its financial results for the first quarter of FY2027 (ending June 30, 2026). The company reported a consolidated revenue of ₹7,043 crore, marking a significant 21% year-on-year increase. Consolidated Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) rose by 28% to ₹1,092 crore, while consolidated Profit After Tax (PAT) saw a substantial jump of 34% to ₹581 crore.
Why this matters
This strong financial performance indicates healthy demand and operational efficiency across the company's business segments. The significant revenue and profit growth, coupled with strategic capacity expansion plans, suggest a positive outlook for shareholder value. The appointment of new statutory auditors and a business restructuring initiative also point towards a focus on corporate governance and operational streamlining.
The backstory
Apollo Hospitals has consistently invested in expanding its healthcare network and digital services. The company's strategy involves both organic growth through new hospital launches and bed additions, as well as inorganic expansion and enhancement of its pharmacy and digital health platforms. The Apollo HealthCo segment, encompassing pharmacy and digital health, has been a key focus area for growth.
What changes now
The company has approved the appointment of Price Waterhouse Chartered Accountants LLP as statutory auditors for a five-year term. Additionally, a proposed slump sale of the procurement and wholesale distribution undertaking of Apollo HealthCo to Apollo Consumer Products Limited is underway to enhance group efficiency. This move is expected to be completed by October 1, 2026.
Risks to watch
Investors should monitor ongoing legal proceedings concerning land allotment in Karnataka, although management expresses confidence in a favorable outcome. Additionally, potential cost increases related to new Labour Codes could impact profitability in the future.
Peer comparison
While specific peer comparisons are not detailed in the filing, Apollo Hospitals operates in a competitive healthcare market with other major hospital chains in India. Its integrated model, including healthcare services and a strong digital presence, differentiates it.
Context metrics (time-bound)
- Revenue Growth: 21% YoY in Q1 FY2027.
- PAT Growth: 34% YoY in Q1 FY2027.
- Bed Addition Plan: Over 5,800 beds planned over the next five years.
- Auditor Appointment: Term of five years commencing FY2032.
What to track next
Investors will be keen to observe the execution of the aggressive 5,800-bed expansion plan and the successful completion of the business restructuring. Monitoring updates on the legal matters in Karnataka will also be crucial.